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Abstract
Unrepaired DNA double-strand breaks (DSBs) are a major cause for genomic instability.
Therefore, upon detection of a DSB a rapid response must be assembled to coordinate the proper
repair/signaling of the lesion or the elimination of cells with unsustainable amounts of DNA damage.
Three members of the PIKK family of protein kinases -ATM, ATR and DNA-PKcs- take the lead
and initiate the signaling cascade emanating from DSB sites. Whereas DNA-PKcs activity seems to
be restricted to the phosphorylation of targets involved in DNA repair, ATM and ATR
phosphorylate a broad spectrum of cell cycle regulators and DNA repair proteins. In the canonical
model, ATM and ATR are activated by two different types of lesions and signal through two
independent and alternate pathways. Specifically, ATR is activated by various forms of DNA
damage, including DSBs, arising at stalled replication forks ("replication stress"), and ATM is
responsible for the signaling of DSBs that are not associated with the replication machinery
throughout the cell cycle. Recent evidence suggests that this model might be oversimplified and that
coordinated crosstalk between ATM and ATR activation routes goes on at the core of the DNA
damage response.
Introduction
Accumulation of DNA damage at the cellular level is
linked to a number of phenotypes at the organism level
including progeria, neurodegeneration and cancer. There-
fore, understanding how cells respond to lesions in their
DNA has become a central area of research in biomedical
sciences. In particular, significant effort has been made in
elucidating the components and mechanisms of the sign-
aling pathways that alert about the existence of DSBs [1].
Our current understanding is based on a model with two
alternative routes. If DSBs arise at the replication fork (the
still not fully defined concept of "replication stress"), acti-
vation of the ATR pathway is responsible for the signaling
of damaged DNA. Alternatively, and in agreement with its
general role in cell-cycle checkpoints [2], ATM is responsi-
ble for the signaling of other types of DSBs that are not
restricted to replicating cells. In addition to ATM and ATR,
which are rapidly recruited to the break sites and are the
earliest transducers of the DNA damage response, the
strength of each pathway is reinforced by the subsequent
activation of an additional downstream kinase. Specifi-
cally, whereas ATM-dependent responses are amplified by
the activation of the kinase Chk2, ATR-dependent activa-
tion of Chk1 takes place in response to "replication
stress".
The two types of DSBs can artificially be mimicked in the
laboratory. Typically, chemicals such as hydroxyurea
Published: 17 May 2006
Cell Division 2006, 1:7 doi:10.1186/1747-1028-1-7
Received: 08 May 2006
Accepted: 17 May 2006
This article is available from: http://www.celldiv.com/content/1/1/7
© 2006 Cuadrado et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cell Division 2006, 1:7 http://www.celldiv.com/content/1/1/7
Page 2 of 4
(page number not for citation purposes)
(HU) or aphidicolin are used to induce activation of ATR,
and exposure to ionizing radiation (IR) for activation of
the ATM pathway. In addition, the levels of phosphoryla-
tion of ATM and ATR targets serve as a quantitative read-
out of the kinase activities. For instance, Chk2 and Chk1
phosphorylation are regularly used as a measure of ATM
and ATR activation status, respectively. However, a
number of studies have previously reported that IR, which
supposedly only activates ATM, also leads to noticeable
phosphorylation of Chk1. One possible interpretation is
that this phosphorylation is derived from "accidental"
phosphorylation of Chk1 by ATM, particularly at the high
doses of IR used in this type of experiment [3]. However,
both Chk1 and ATR are known regulators of the G2/M
checkpoint in response to IR. [4-6], arguing in favor of a
functional role of Chk1 phosphorylation in radiation
responses. Moreover, ATR, but not ATM, is known to be
the main kinase mediating Chk1 phosphorylation. Data
now coming from several groups finally resolves this con-
troversy and provides a novel molecular framework to
understand the cellular responses to IR [7-10].
Discussion
A novel concept: ATM-dependent ATR activity
The key observation in these works is that although ATM
and ATR are both upstream of Chk1 phosphorylation in
response to IR, the presence of active ATM in the cell is not
sufficient and still requires ATR activity for the modifica-
tion of Chk1. In other words, the data suggest the exist-
ence of active crosstalk among ATM and ATR signaling
pathways in response to IR which works through ATM-
dependent activation of ATR. But how is ATR activity reg-
ulated by ATM? One possibility is that ATR would be
directly activated by ATM. In this context, and taken that
ATM autophosphorylation is supposed to be necessary for
its activation [11], it is tempting to speculate that ATM
dependent phosphorylation of ATR could similarly stim-
ulate its activity. However, there is no evidence that sup-
ports this hypothesis. In addition, whereas pre-treatment
of cells with DNA damage stimulates the activity of puri-
fied ATM, there is no difference in the in vitro activity of
ATR whether is purified from damaged or intact cells [12].
Another possibility is that instead of promoting its kinase
activity, ATM regulates the accessibility of ATR to its
downstream targets. In fact, recruitment to the sites of
damage is probably the most critical level of regulation of
PIKK activity [13,14]. The evaluation of ATR recruitment
to IR-damaged chromatin revealed that ATR relocalization
is indeed dependent on ATM [7-10].
ATM dependent loading of RPA to DSBs
Within the cell, ATR exists in a complex with ATRIP (ATR
interacting protein) and defects in ATRIP are associated
with concomitant abrogation of the ATR/Chk1 pathway
[15]. Additionally, ATRIP recruitment to DSBs is mediated
by its interaction with the ssDNA binding complex RPA
(replication protein A) [16]. Therefore, ATM dependent
recruitment of ATR could be mediated by the regulation of
the pathway at any of these upstream steps (ssDNA gener-
ation, RPA or ATRIP modification...). Consistently, local-
ization studies supported the idea of the regulation of the
ATR/Chk1 pathway at the level of RPA, since RPA redistri-
bution into IR-induced foci was shown to be dependent
on ATM. In addition, both ATR and RPA recruitment to
IR-induced DSBs were also dependent on MRN (Mre11/
Rad50/Nbs1) complex. However, given that the MRN
complex recruits ATM to DSBs [14] these data could be
conceptually equivalent to the dependence on ATM. In
any case, the work of Jazayeri and colleagues showed evi-
dence arguing that a nuclease deficient mutation of
Mre11, which they point out has no effect on ATM activa-
tion in their experimental conditions, leads to defective
RPA localization to DSBs[9]. In summary, these data sug-
gest that ATM dependent localization of ATR to IR-dam-
aged DNA works at the level of RPA loading, likely
through the generation of ssDNA. Further work should be
done to elucidate how ssDNA generation and RPA load-
ing in response to IR are controlled by ATM.
ATM and ATR kinase activities: unanswered questions
In contrast to the crosstalk between ATM and ATR that is
activated in response to IR, the analysis of the response to
"replication stress" published in these recent reports is
still consistent with the canonical model and places ATM/
Chk2 and ATR/Chk1 in two alternative and non-interact-
ing pathways. Noteworthy, our data (8 and unpublished)
consistently detected an increased loading of ATR onto
HU-damaged chromatin in the absence of ATM activity. It
is possible that both signaling mechanisms compete for
the signaling of DSBs during replication so that the
absence of ATM could lead to an increased ATR response
or vice versa. Another intriguing point is the ATM-depend-
ent phosphorylation of Chk2 in S/G2 phase. In our exper-
iments, ATM dependent phosphorylation of its targets
occurs whenever a DSB is present (throughout the cell
cycle in response to IR or restricted to S phase in response
to "replication stress"). However, there is no data that
strongly supports a functional role for Chk2 in the signal-
ing of stalled replication forks. Are ATM/ATR promiscu-
ous enzymes that indiscriminately phosphorylate
proteins carrying [S/T]Q motifs once they are activated? Is
the specificity given just by the accessibility of the sub-
strates at the sites of DSBs? In the light of these facts, delin-
eating the specific in vivo functions of newly identified
ATM/ATR-dependent phosphorylation events should be a
critical avenue of future research.
Cell-cycle restricted ATR activity: the CDK connection
Finally, an additional and perhaps more crucial point of
these recent publications focused on the study of how theCell Division 2006, 1:7 http://www.celldiv.com/content/1/1/7
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activation of the ATR/Chk1 pathway is restricted to post-
replicative cells. Two of these reports [8,9] showed that
Chk1 phosphorylation in response to IR is restricted to S
and G2 cells. Significantly, the development of a flow-
cytometry based approach for the evaluation of Chk1
phosphorylation, demonstrated that ATR activity is not
uniform throughout the cell cycle. In contrast, Chk1 phos-
phorylation starts to be detectable in early S and is maxi-
mum by the end of G2. Why this pathway is not active in
G1 cells remains uncertain. One possibility is simply that
members of the pathway are only expressed in S/G2. Con-
sistently, a recent report claimed that ATR is not expressed
in non-replicating lymphocytes [17]. However, this
restriction seems to be limited to G0 cells, since all com-
ponents of the ATR pathway (RPA, ATRIP, ATR and Chk1)
are present in G1 (unpublished data). Alternatively, it is
possible that some of the members of the pathway need
to be "pre-activated" in S-G2 in order to be able to func-
tion. The absence of ATR activity in G1 followed by a pro-
gressive increase throughout S-G2 supports such a view
and is reminiscent of the activity of cyclin-dependent
kinases. Importantly, the joint work of the laboratories of
Steve Jackson and Jiri Lukas showed experimental evi-
dence for such a model. Specifically, the use of the broad
range inhibitor of CDK activity Roscovitin led to a reduc-
tion in IR-induced Chk1 phosphorylation [9]. Evaluating
the molecular mechanisms that connect CDK activity with
ATR "licensing" will certainly become an active area of the
DNA-damage studies.
Conclusion
Elucidation of an active crosstalk between ATM and ATR
signaling routes is a live example that there is still room
for refining canonical models of molecular biology based
on exploiting the cases in which the data does not fit with
the existing model (the IR-induced G2/M checkpoint, in
this case). On the technical level, we expect that the incor-
poration of flow cytometry protocols[8] onto DNA-dam-
age signaling events will help in our understanding the
molecular choreography of cell cycle checkpoints. Finally,
the concept of CDK mediated "licensing" of the ATR path-
way, nicely supported by S. Jackson's data comes timely in
the context of other related works. There is mounting evi-
dence from both system models like yeast [18] as well as
human cells [19], that CDK activity coordinates the
assembly of the proper repair complexes in different
stages of the cell cycle. In particular, suppression of the
homologous recombination (HR) pathway of DNA repair
in G1 is of critical importance since HR activity in the
absence of the proper sister chromatid could easily lead to
the generation of chromosome aberrations and transloca-
tions. In the DNA damage response field we are used to
evaluating how ATM and ATR activities finally converge
into silencing of CDK activities and thus activation of cell-
cycle checkpoints. These recent studies maybe just the "tip
of the iceberg" in the emerging reverse concept; namely
that CDKs control cell-cycle specific DNA damage signal-
ing pathways.
Abbreviations
DSB: DNA double-strand break; PIKK: phosphatidyl-
inositol 3 kinase like protein kinase; ATM: Ataxia Tel-
angiectasia mutated; ATR: ATM and Rad3-related; DNA-
PKcs: DNA-dependent protein kinase catalytic subunit,
HU: hydroxyurea; IR: ionizing radiation; ssDNA: single
stranded DNA; RPA: replication protein A; CDK: cyclin-
dependent kinase.
Sequence of events in ATM→ ATR dependent signaling of  DSBs in S/G2 cells Figure 1
Sequence of events in ATM→ ATR dependent signal-
ing of DSBs in S/G2 cells. (1) Recuitment of the MRN 
complex to the DSB. (2) Recuitment/activation of ATM to 
DSBs. (3) ATM dependent stimulation of the Mre11-depend-
ent 5' to 3' nuclease activity. (4) Generation of ssDNA. (5) 
Recruitment of RPA to the generated ssDNA. (6) Recruit-
ment of the ATRIP/ATR complex to ssDNA-bound RPA. (7) 
ATR dependent activation of Chk1. (8) Inhibition of the spe-
cific CDK activity responsible for S and/or G2/M progres-
sion; in other words, execution of the checkpoint. (9) 
Control of the ssDNA/RPA/ATR pathway by CDK activity. 
The numbers followed by an asterisk (3,4 and 9) point to the 
less understood concepts of the model: (3)* How does ATM 
stimulate Mre11 nuclease activity? (4)* To what extent is 
Mre11 nuclease activity responsible for the ssDNA genera-
tion in response to IR-induced DSBs? And, most importantly; 
(9)* how does CDK activity "preactivate" the ATR/Chk1 
pathway?
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